NEW WELLLINK
871634
VIBO
871245
MTD
835579
REFORMER
833030
Hunan Sundy Science And Technology
300515
CN Stock MarketDetailed Quotes
688428 InnoCare Pharma
- 18.60
- -0.20-1.06%
Market Closed Mar 7 15:00 CST
32.78BMarket Cap-87.32P/E (TTM)
18.86High18.32Low62.28KlotVolume18.62Open18.80Pre Close115.46MTurnover2.34%Turnover RatioLossP/E (Static)1.76BShares19.3452wk High4.82P/B4.95BFloat Cap7.2852wk Low22.56Limit Up266.28MShs Float19.34Historical High15.04Limit Down2.87%Amplitude7.28Historical Low--Dividend TTM18.54Avg Price29.12KlotAsk--Div YieldTTM100Lot Size30.00KlotBid
InnoCare Pharma News
Nuocheng Jianhua: Hong Kong Stock Announcement: Monthly Report on Securities Changes
Hong Kong Stock Announcement: Monthly Statement of Changes in Securities
Nuochengjianhua: Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the announcement of the 10th American Multiple Sclerosis Treatment and Research Committee (ACTRIMS) Annual Forum in 2025 to release clinical phase II data on the treatment of relapse-relieving multiple sclerosis with obutinib
Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the announcement that the 10th American Multiple Sclerosis Treatment and Research Committee (ACTRIMS) Annual Forum in 2025 released clinical phase II data on the treatment of relapse-relieving multiple sclerosis with obutinib
Nuochengjianhua: Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the CDE approval for the registered phase III clinical trial of the BCL2 inhibitor ICP-248 (Mesutoclax) combined with obutinib for first-line CLL/SLL treatment
Nuochengjianhua Pharmaceutical Co., Ltd. voluntarily disclosed the announcement that the CDE approved a registered phase III clinical trial of the BCL2 inhibitor ICP-248 (Mesutoclax) combined with obutinib for first-line CLL/SLL treatment
Nuocheng Jianhua: Hong Kong Stock Announcement: Monthly Report on Securities Changes
Hong Kong Stock Announcement: Monthly Statement of Changes in Securities
Hong Kong Stock Announcement: Next Day Disclosure Statement
Nochengjianhua: Hong Kong Stock Announcement: Next Day Disclosure Statement
Hong Kong Stock Announcement: Next Day Disclosure Statement
Nochengjianhua: Hong Kong Stock Announcement: Next Day Disclosure Statement
Hong Kong Stock Announcement: Next Day Disclosure Statement
Nuocheng Jianhua: Hong Kong Stock Announcement: List of Directors and Their Roles and Functions
Nuochengjianhua: Opinions of the Nomination Committee of the Board of Directors of Nuochengjianhua Pharmaceutical Co., Ltd. on the appointment of an independent non-executive director
Nuocheng Jianhua: Independent Non-Executive Director Candidate Statement and Commitment of Nuocheng Jianhua Pharmaceutical Co., Ltd. - Kunliang Guan (Guan Kunliang)
Nuocheng Jianhua: Statement and Commitment of the Independent Non-Executive Director Nominee of Nuochengjianhua Pharmaceutical Co., Ltd. - Kunliang Guan (Guan Kunliang)
Nuocheng Jianhua: Announcement of Nuocheng Jianhua Pharmaceutical Co., Ltd. on the appointment of an independent non-executive director
Hong Kong Stock Announcement: List of Directors and Their Roles and Functions
Nuochengjianhua Pharmaceutical Co., Ltd. Independent Non-Executive Director Nominee Statement and Commitment-Kunliang Guan
